Discovering a Common Goal,
Discovering a Cure
ALS Drug Development Database
ALS Forum e-Newsletter Archives
Preclinical Study Resources
General ALS Info
International ALS Resources
ALS Research Resources
Potential Funding Sources
Neurophage Pharmaceuticals Awarded Second Grant for Parkinson's Disease Program
January 31, 2014
Cambridge, MA-based Neurophage Pharmaceuticals has been awarded a second grant from the Michael J. Fox Foundation for Parkinson's Research (MJFF) for further development of its sec...
Neuralstem Raises $19.6M in a Stock Offering to Support ALS Therapy Through Phase II
January 16, 2014
Neuralstem's Phase II trial in ALS will likely get a boost in funding through their recent $19.6M stock offering. Neuralstem, which received financial support from the National Ins...
Looking Back at Advances in ALS for 2013
January 15, 2014
The ALSTDI has created an engaging and interactive timeline of last year's key milestones in ALS research and development. The summary covers notable therapies in clinical developm...
Glaxo Compound Slows Lou Gehrig's Disease in Animal Models
December 17, 2013
Stress granules are dense aggregates that contain RNA and protein and appear in the cytosol under conditions of stress. A recent study, published online on December 15 in Nature Ge...
Project A.L.S. Teams Up with Eli Lilly to Find Drugs for ALS
December 13, 2013
Eli Lilly is partnering with Project A.L.S. in order to expand the pipeline of potential drugs for ALS. Under the agreement, Project A.L.S. will screen small molecules that were or...
The ALS Forum was developed by Prize4Life, Inc.
P.O. Box 425783 | Cambridge, MA 02142 | 617.500.7527
© 2014 Prize4Life, Inc.
Identified content provided through
a partnership with the Alzforum